1785
In the present study, arsenic trioxide was given intravenously for 42 days to a 56-year-old female patient suffering from chemotherapy/ATRA-resistant APL, with 43% APL blasts in the bone marrow and elevated D-dimers.
 ( potential therapeutic event: given ,  56-year-old female patient: Subject, 56-year-old: Subject.Age, female: Subject.Gender, arsenic trioxide: Treatment, arsenic trioxide: Treatment.Drug, chemotherapy/ATRA-resistant APL: Treatment.Disorder, 42 days: Treatment.Duration) 
Locate the role in the text that participated in the event based on the event type and return it in the event list. 
 Option: Event type: adverse event,potential therapeutic event, Arguments type: Treatment.Disorder,Treatment.Time_elapsed,Treatment.Dosage,Subject.Race,Treatment.Drug,Treatment.Route,Subject.Disorder,Treatment.Freq,Treatment,Effect,Subject.Population,Treatment.Duration,Combination.Drug,Subject,Subject.Age,Subject.Gender. 
Text: {0} 
Answer:
 ( potential therapeutic event: given ,  56-year-old female patient: Subject, 56-year-old: Subject.Age, female: Subject.Gender, arsenic trioxide: Treatment, arsenic trioxide: Treatment.Drug, chemotherapy/ATRA-resistant APL: Treatment.Disorder, 42 days: Treatment.Duration) 